I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company...

Investigators from Northwestern University Feinberg School of Medicine and Invitae (NYSE: NVTA), a medical genetics company, will present the results of a collaborative study on genetic testing...

From November 4th to November 6th, this year's American Transcatheter Cardiovascular Therapeutics Conference (TCT2021) was officially held with on-site attendance in Orlando, Florida, and...

Partnership will accelerate autonomous shuttle offerings for transit authorities across America VANCOUVER, BC, Nov. 8, 2021 /PRNewswire/ -- GreenPower Motor Company Inc. (NASDAQ: GP) (TSXV: GPV)...

Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced preclinical data from the Company's lead program for innate...